Polyphenol-Rich Aronia melanocarpa Juice Consumption Affects LINE-1 DNA Methylation in Peripheral Blood Leukocytes in Dyslipidemic Women by Stojković, Ljiljana et al.
ORIGINAL RESEARCH
published: 17 June 2021
doi: 10.3389/fnut.2021.689055
Frontiers in Nutrition | www.frontiersin.org 1 June 2021 | Volume 8 | Article 689055
Edited by:
Rosita Gabbianelli,
University of Camerino, Italy
Reviewed by:
Fabio Caradonna,
University of Palermo, Italy
Nenad Naumovski,





This article was submitted to
Nutrigenomics,
a section of the journal
Frontiers in Nutrition
Received: 31 March 2021
Accepted: 26 May 2021
Published: 17 June 2021
Citation:
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Cardiovascular disease (CVD) is associated with alterations in DNA methylation and
polyunsaturated fatty acid (PUFA) profile, both modulated by dietary polyphenols. The
present parallel, placebo-controlled study (part of the original clinical study registered
as NCT02800967 at www.clinicaltrials.gov) aimed to determine the impact of 4-week
daily consumption of polyphenol-rich Aronia melanocarpa juice (AMJ) treatment on Long
Interspersed Nucleotide Element-1 (LINE-1) methylation in peripheral blood leukocytes
and on plasma PUFAs, in subjects (n = 54, age range of 40.2 ± 6.7 years) at
moderate CVD risk, including an increased body mass index, central obesity, high
normal blood pressure, and/or dyslipidemia. The goal was also to examine whether
factors known to affect DNA methylation (folate intake levels, MTHFR C677T gene
variant, anthropometric and metabolic parameters) modulated the LINE-1 methylation
levels upon the consumption of polyphenol-rich aronia juice. Experimental analysis of
LINE-1 methylation was done by MethyLight method. MTHFR C677T genotypes were
determined by the polymerase chain reaction–restriction fragment length polymorphism
method, and folate intake was assessed by processing the data from the food frequency
questionnaire. PUFAs were measured by gas–liquid chromatography, and serum lipid
profile was determined by using Roche Diagnostics kits. The statistical analyses were
performed using Statistica software package. In the comparison after vs. before the
treatment period, in dyslipidemic women (n = 22), we observed significant decreases in
LINE-1 methylation levels (97.54 ± 1.50 vs. 98.39 ± 0.86%, respectively; P = 0.01) and
arachidonic acid/eicosapentaenoic acid ratio [29.17 ± 15.21 vs. 38.42 (25.96–89.58),
respectively; P = 0.02]. The change (after vs. before treatment) in LINE-1 methylation
directly correlated with the presence of MTHFR 677T allele, average daily folate intake,
and the change in serum low-density lipoprotein cholesterol but inversely correlated with
the change in serum triacylglycerols (R= 0.72, R2 = 0.52, adjusted R2 = 0.36, P= 0.03).
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The current results imply potential cardioprotective effects of habitual polyphenol-rich
aronia juice consumption achieved through the modifications of DNA methylation pattern
and PUFAs in subjects at CVD risk, which should be further confirmed. Hence, the
precision nutrition-driven modulations of both DNA methylation and PUFA profile may
become targets for new approaches in the prevention of CVD.
Keywords: Aronia melanocarpa, polyphenols, polyunsaturated fatty acids, LINE-1, methylation, peripheral blood
leukocytes, cardiovascular risk
INTRODUCTION
Pathogenesis of human chronic diseases, such as cancer and
cardiovascular disease (CVD), is related to aberrant global and
locus-specific DNA methylation patterns (1, 2). Methylation of
DNA, catalyzed by DNA methyltransferases (DNMTs), is one
of the main epigenetic processes, which most commonly occurs
at cytosine-guanine (CpG) dinucleotide clusters and results in
downregulation of gene expression (3).
Various exogenous and endogenous factors modulate DNA
methylation. Folate (vitamin B9) is found in a variety of plant
foods and participates in one-carbon metabolism, resulting in
the formation of S-adenosyl-methionine (SAM) that acts as a
methyl group donor (4). Methylenetetrahydrofolate reductase
(MTHFR) activation catalyzes the conversion of homocysteine to
methionine, which is a direct precursor of SAM. The presence
of T allele at a common C677T (Ala222Val) MTHFR gene
polymorphic site is associated with a decreased activity of the
enzyme, thus reducing the methyl group bioavailability and
subsequently inhibiting the methylation of DNA (5).
Methylation of Long Interspersed Nucleotide Element-1
(LINE-1), the largest member of the LINE retrotransposon
family of DNA repeat elements (comprising about 17% of
the human genome) (6), is considered a surrogate marker of
global DNA methylation (7, 8). Methylation status of LINE-1
in peripheral blood leukocytes is associated with metabolic
parameters, such as blood glucose and lipid profiles (9, 10),
and global DNA methylation in these cells has been found to
depend on demographic and lifestyle factors: age, gender, blood
pressure, body mass index (BMI), and dietary habits, including
polyunsaturated fatty acid (PUFA) supplementation (9, 11–14).
In addition, the studies have reported that the inhibition of DNA
methylation may prevent the progression of cancer and CVD
(1, 2, 15). Hence, the methylation status of LINE-1 in peripheral
blood leukocytes represents a potential CVD biomarker, and
certain lifestyle factors, like diet, may modulate cardiovascular
risk by influencing alterations in DNAmethylation patterns, thus
Abbreviations: AA, arachidonic acid; BMI, body mass index; COMT, catechol-
O-methyltransferase; CVD, cardiovascular disease; DBP, diastolic blood pressure;
DNMTs, DNA methyltransferases; EDTA, ethylenediaminetetraacetic acid;
EPA, eicosapentaenoic acid; Glu, glucose; HDL-C, high-density lipoprotein
cholesterol; LDL-C, low-density lipoprotein cholesterol; LINE-1, Long
Interspersed Nucleotide Element-1; MTHFR, methylenetetrahydrofolate reductase;
MUFA, monounsaturated fatty acid; PCR, polymerase chain reaction; PUFA,
polyunsaturated fatty acid; SAH, S-adenosyl-L-homocysteine; SAM, S-adenosyl-
methionine; SBP, systolic blood pressure; SFA, saturated fatty acid; TAG,
triacylglycerols; TC, total cholesterol; WC, waist circumference.
emphasizing the importance of precision nutrition strategies in
the prevention of CVD.
Regular consumption of Aronia melanocarpa juice is
associated with CVD beneficial effects in human studies (16–18)
and animal models (19). Aronia is rich in bioactive polyphenols
(20) and, compared with other berry fruits, contains higher levels
of polyphenolic compounds (21). Of note, dietary polyphenols
are reported to favorably modulate DNA methylation status by
inhibiting DNMT activity (22). In addition, aronia polyphenols
affected the composition of plasma PUFAs in individuals at
CVD risk (23). To the best of our knowledge, no study has
examined the relation between polyphenols contained in aronia
berry and DNA methylation status. Therefore, the present
parallel, placebo-controlled, 4-week study aimed to investigate
the interconnection between daily consumption of polyphenol-
rich aronia juice and LINE-1 methylation in peripheral blood
leukocytes and plasma fatty acids, in subjects at moderate CVD
risk. We also examined whether folate intake and MTHFR
C677T gene variant, as well as the anthropometric and metabolic
parameters, modulated the LINE-1 methylation levels upon the
consumption of polyphenol-rich aronia juice.
MATERIALS AND METHODS
Study Design, Study Subjects, and
Intervention Treatments
The current research represents a parallel, placebo-controlled,
4-week nutritional intervention. The research is designed as a
substudy, forming part of the original clinical study that lasted 6
months, and is registered at ClinicalTrials.gov as NCT02800967.
The original study included nonsmoking adults at moderate
CVD risk, defined as the presence of at least one of the
following: increased BMI (25–30 kg/m2), central obesity (waist
circumference ≥ 80 cm for women and ≥ 94 cm for men), and
high normal blood pressure [systolic/diastolic blood pressure
(SBP/DBP) > 120/80, ≤ 139/89mm Hg]. Exclusion criteria
were the presence of chronic disease, self-reported allergy to
polyphenols, pregnancy, lactation, blood donation 16 weeks
before the start of the study, and parallel participation in another
clinical trial. During the course of the study, the participants were
asked to follow their habitual diet, including study treatments as
part of it, and to do their usual physical activity. They were also
asked to strictly refrain from berries and berry products and to
avoid excess amounts of polyphenol-rich food, inclusive of olive
oil, green tea, and nuts.
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For purposes of the current substudy, additional a posteriori
inclusion criterion was the presence of dyslipidemia defined as
either elevated serum total cholesterol (≥5.2 mmol/l), elevated
low-density lipoprotein cholesterol (LDL-C) (≥3.4 mmol/l),
or elevated serum triacylglycerols (≥1.7 mmol/l). In order
to address the objectives of the substudy, 54 subjects were
included, whose LINE-1 methylation status in peripheral blood
leukocytes and MTHFR C677T gene variant were additionally
analyzed. They received either original polyphenol-rich A.
melanocarpa juice (assigned as AMJ treatment, N = 34 subjects)
or polyphenol-free placebo beverage (assigned as PLB treatment,
N = 20 subjects). The research flow diagram is shown in Figure 1.
The original polyphenol-rich aronia juice used in the study
was registered at the Serbian Ministry of Health as a dietary
supplement and was donated from “Nutrika” LTD (Belgrade,
Serbia). The placebo drink was made to match the appearance,
taste, and nutritional composition of the original aronia juice, but
without bioactive polyphenols. It was previously reported that
the daily amount of 100ml of the placebo was safe for human
consumption (24). Total polyphenols in the original aronia juice
were determined using a modified Folin-Ciocalteu method (25),
and it was found that the consumed daily amount of 100ml
of the juice contained 1,177.11mg of gallic acid equivalents of
polyphenols. Proanthocyanidins were highly represented among
the contained polyphenols, as demonstrated in the analysis of
the composition of herein used aronia juice (24). The study
compliance was assessed according to returned empty bottles of
intervention drinks and self-reports.
The study protocol adhered to the regulations of the 1975
Declaration of Helsinki and was approved by Clinical Hospital
Centre Zemun, Belgrade, Serbia, Ethics Committee Approval,
No: 2125, 2013. The written informed consent was given by all
participants before the commencement of the study.
Sample Collection
Study participants were instructed for overnight fasting,
and venous blood was collected the next morning between
8 and 9 AM into the sample tubes for serum and
ethylenediaminetetraacetic acid (EDTA)-evacuated tubes.
The sample collection was done at two time points, before and
after the corresponding 4-week treatments (AMJ and PLB).
Assessment of Study Variables
For the assessment of baseline dietary intake, trained staff
conducted structured interviews with study subjects and
collected data by using the food frequency questionnaire and
repeated 24-h dietary recalls. The subjects were assisted with
125-item photo-booklet containing simple foods and composite
dishes (26). Data from dietary recalls were analyzed using the
nutritional platform for comprehensive diet evaluation (26, 27).
Bio-impedance analyzer TANITA UM072 balance (TANITA
Health Equipment H.K. Ltd, Hong Kong, China) was used for
the determination of body weight. Total cholesterol, high-density
lipoprotein cholesterol (HDL-C), LDL-C, triacylglycerols, and
glucose from serum were determined by Roche Diagnostics Kits,
using the chemistry analyzer (Cobas c111, Roche Diagnostics,
Basel, Switzerland).
The procedure of determination of plasma phospholipid
fatty acids composition was previously described in detail by
Pokimica et al. (23). Briefly, plasma lipids were extracted
using a 2:1 chloroform–methanol mixture with 2,6-di-tert-
butyl-4-methylphenol (10 mg/100ml) added as an antioxidant.
Phospholipids were separated from other lipid subclasses on
a thin-layer chromatography silica plate using a mixture of
petroleum ether, diethyl ether, and acetic acid (87:12:1). The
methyl esters of fatty acids were obtained by transmethylation
with 2M sodium hydroxide in methanol, at 85◦C for 1 h,
and with 1M sulfuric acid in methanol, at 85◦C for 2 h. The
mixture was cooled down to room temperature and centrifuged
at 1,860 × g for 15min, and the upper phase was dried
up using a stream of nitrogen. The fatty acid methyl esters
were recovered in hexane and separated by using RTX 2330
capillary column (60m× 0.25mm × 0.2µm; Restek, Bellefonte,
PA, United States), on Shimadzu GC-2014 gas chromatograph
(Kyoto, Japan) with flame ionization detector. The flow of
air, hydrogen, and helium (carrier gas) was 320, 30, and 5
ml/min, respectively. The temperature of the detector was
260◦C and of the injection port 220◦C. The initial column
temperature of 140◦C was maintained for 5min and then
increased to 220◦C at a rate of 3◦C/min, and 220◦C was
kept for 20min. Fatty acids were identified by comparing peak
retention times with calibration mixtures (PUFA-2, Supelco,
Bellefonte, PA, United States, and 37 FAMEs mix, Sigma
Chemical Co., St. Louis, MO, United States). The amounts of
individual fatty acids in plasma phospholipids were presented
as the relative area percentage of the total pool of detected
fatty acids.
Analysis of LINE-1 Methylation
The fasting peripheral blood samples of each participant,
collected with EDTA before and after the corresponding
treatments, were used for the total leukocyte genomic
DNA isolation, by a phenol–chloroform extraction-based
method (28). The quantity of DNA was estimated with
BioSpecnano spectrophotometer (Shimadzu Biotech, Kyoto,
Japan).
Five hundred (500) ng of each sample genomic DNA was
used for sodium bisulfite conversion with EpiTect R© Bisulfite kit
(Qiagen, Hilden, Germany). Bisulfite-converted DNA was then
used for the quantification of LINE-1methylation by MethyLight
real-time PCR. To normalize DNA input, an Alu sequence-based
real-time PCR control reaction was performed in parallel with
each LINE-1 reaction. The method was previously developed
and validated, its precision and reproducibility were confirmed
(8, 29), and the currently used protocol was described in detail by
Božović et al. (29).
MTHFR Genotyping
The genotypes of MTHFR C677T variant were determined from
the total leukocyte genomic DNA samples, by PCR–restriction
fragment length polymorphism method reported in Coppedè
et al. (30), in all subjects included in the methylation analysis.
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FIGURE 1 | Study flow diagram. N, number of subjects; AMJ, polyphenol-rich Aronia melanocarpa juice treatment; PLB, polyphenol-free beverage;
placebo, treatment.
Statistical Analyses
The comparisons of MTHFR C677T genotype frequencies
between groups and estimation of deviations from
Hardy–Weinberg equilibrium were done with Fisher’s exact
test and the χ2 test. Due to a small number of the TT genotype
carriers (N < 3) in at least one of the analyzed groups, we
applied the dominant genotype model, CT + TT vs. CC, instead
of the additive. Depending on the distribution of continuous
variables (age, average daily energy intake, average daily folate
intake, SBP, DBP, waist circumference, BMI, serum glucose,
triacylglycerols, total cholesterol, HDL-C, LDL-C, plasma fatty
acids, and LINE-1 methylation levels), tested by the Shapiro–
Wilks test, the appropriate parametric or non-parametric tests
were performed. Between-group comparisons were done using
a t-test or the Mann–Whitney U-test, while within-group
comparisons (after vs. before each treatment) were done by t-test
for dependent samples or the Wilcoxon matched-pairs test, for
normally and non-normally distributed data, respectively. The
treatment effects were investigated in the complete sample and
in women and men, separately. The relationship between LINE-1
methylation and the anthropometric and metabolic parameters
(age, average daily folate intake, average daily energy intake, SBP,
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TABLE 1 | Baseline characteristics of the study participants.
AMJ PLB P
No. of subjects 34 20
Age (years) 41.1 ± 6.6 38.5 ± 6.8 0.17
Average daily energy intake (kCal) 2075 ± 555 1745 (1168–3385)# 0.29
Average daily folate intake (µg) 239.7 ± 75.2 203.3 (98.2–461.5)# 0.54
SBP (mmHg) 118.3 ± 13.4 120.6 ± 16.2 0.57
DBP (mmHg) 73.2 ± 10.0 74.0 ± 13.7 0.82
Waist circumference (cm) 89.8 ± 10.9 92.2 ± 15.7 0.51
BMI (kg/m2 ) 27.4 ± 3.5 27.8 ± 6.2 0.78
Glucose (mmol/l) 4.8 (3.8–7.2)# 5.1 ± 0.8 0.27
TAG (mmol/l) 0.9 (0.4–4.1)# 0.9 (0.5–5.0)# 0.72
TC (mmol/l) 5.5 ± 1.1 5.2 ± 1.0 0.27
HDL-C (mmol/l) 1.5 (0.8–2.9) # 1.6 ± 0.4 0.54
LDL-C (mmol/l) 3.5 ± 0.9 3.3 ± 1.0 0.56
†
MTHFR C677T genotype, No. (%)
CC 15 (44.1) 7 (35.0)
CT + TT 19 (55.9) 13 (65.0) 0.58
Continuous variables with a normal distribution are presented as mean ± standard deviation; #continuous variables with a non-normal distribution are presented as median
(minimum–maximum); P-values related to the between-treatment difference in the variable distribution, significant difference at P < 0.05.
†
The observed MTHFR C677T genotype frequencies are consistent with Hardy–Weinberg equilibrium, in each analyzed group (χ2 test, P > 0.05).
AMJ, polyphenol-rich Aronia melanocarpa juice treatment; PLB, polyphenol-free beverage, placebo treatment; SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body
mass index; TAG, triacylglycerols; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol.
DBP, waist circumference, BMI, serum glucose, triacylglycerols,
total cholesterol, HDL-C, LDL-C, and plasma fatty acids) was
investigated by regression analyses. T-test/Mann–Whitney
U-test was used to examine the association between LINE-1
methylation and MTHFR genotypes, by a genotype model,
CT+TT vs. CC. In the statistical tests, P < 0.05 were considered
statistically significant. The statistical analyses were performed
using Statistica 8.0 software package (StatSoft, Inc. 1984-2007).
RESULTS
Baseline Characteristics of the Study
Subjects and Effects of Polyphenol-Rich
Aronia Juice Consumption on
Cardiometabolic Parameters
Baseline characteristics, determined before each of the two
treatments, with polyphenol-rich aronia juice (AMJ) and
polyphenol-free beverage (placebo, PLB), for the whole treated
study groups are shown in Table 1. For the treated groups
separated by gender, the baseline characteristics are shown in
Supplementary Table 1. There were no significant differences
in the baseline parameters (AMJ vs. PLB) within any of the
groups (whole sample, women and men), except for serum total
cholesterol inmen [AMJ vs. PLB= 5.9± 1.0 vs. 4.9± 1.2mmol/l;
P (t-test)= 0.04] (Table 1 and Supplementary Table 1).
Within-group comparisons of treatment effects (after vs.
before treatment) toward anthropometric and metabolic
parameters are presented in Supplementary Table 2.
Even though significant differences were found for DBP,
waist circumference, glucose, and HDL-C [P (t-test for
dependent samples/Wilcoxon matched pairs test) < 0.05]
(Supplementary Table 2), only values for waist circumference
dropped out of the clinical ranges.
Effects of Polyphenol-Rich Aronia Juice
Consumption on LINE-1 Methylation
The comparisons of LINE-1 methylation levels after vs. before
polyphenol-rich AMJ treatment and polyphenol-free beverage
(placebo) treatment (PLB) are presented in Figure 2. Although
the AMJ treatment tended to decrease LINE-1 methylation
levels, there was no significant difference in the whole study
group [after vs. before treatment = 97.93 (93.58–99.84)% vs.
98.16 (93.58–99.91)%; P (Wilcoxon matched pairs test) =
0.14] (Figure 2A). We found a significant decrease in LINE-1
methylation after the AMJ treatment in women (after vs. before
treatment = 97.54 ± 1.50 vs. 98.39 ± 0.86%; P (t-test for
dependent samples)= 0.01) (Figure 2C).
In women, where we demonstrated that polyphenol-rich AMJ
treatment significantly changed LINE-1methylation, themultiple
regression model showed significant effects of average daily
folate intake,MTHFR C677T genotypes (model CT+TT vs. CC),
change (1, after vs. before treatment) in triacylglycerols, and
change (1) in LDL-C on the change (1) in LINE-1 methylation
levels, while controlling for age (R= 0.72, R2 = 0.52, adjusted R2
= 0.36, P = 0.03) (Table 2).
Impact of Polyphenol-Rich AMJ Treatment
on the Profile of Plasma Fatty Acids
Composition of plasma phospholipids fatty acids was analyzed
in women who consumed polyphenol-rich aronia juice, as,
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FIGURE 2 | Comparison of LINE-1 methylation levels (%) before and after treatment in: (A) all subjects on AMJ treatment (N = 34; Wilcoxon matched pairs test,
P = 0.14), (B) all subjects on PLB treatment (N = 20; Wilcoxon matched pairs test, P = 0.10), (C) women on AMJ treatment (N = 22; t-test for dependent samples,
P = 0.01), (D) women on PLB treatment (N = 10; Wilcoxon matched pairs test, P = 0.11), (E) men on AMJ treatment (N = 12; Wilcoxon matched pairs test,
P = 0.53), (F) men on PLB treatment (N = 10; Wilcoxon matched pairs test, P = 0.65). AMJ, polyphenol-rich Aronia melanocarpa juice treatment; PLB,
polyphenol-free beverage, placebo treatment; mean represents normally distributed LINE-1 methylation levels (%); median represents non-normally distributed LINE-1
methylation levels (%); SE, standard error; statistical significance at P < 0.05 (*); N, number of subjects.
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TABLE 2 | Multiple regression analysis for the change (1) in LINE-1 methylation levels (%) in women who consumed polyphenol-rich Aronia melanocarpa juice (AMJ
treatment, N = 22).
Predictor variable β Std. error of β P
Age (years) −0.40 0.21 0.08
Average daily folate intake (µg) 0.49 0.19 0.02
MTHFR C677T genotypes (model CT + TT vs. CC) 0.50 0.19 0.02
1 Triacylglycerols (mmol/l) −0.53 0.20 0.02
1 Low-density lipoprotein cholesterol (mmol/l) 0.46 0.19 0.03
Regression summary: R = 0.72, R2 = 0.52, adjusted R2 = 0.36, P = 0.03.
1: change, after treatment value—before treatment value; significant difference at P < 0.05 (bolded text).
only in these subjects, aronia juice consumption was associated
with a significant change in LINE-1 methylation levels. Profiled
fatty acids are shown for 15 women treated with aronia juice
(Supplementary Table 3), whose plasma samples were available
for the analysis, representing a part of previously published data
(23). Overall baseline plasma phospholipid fatty acids comprised
∼48% SFAs,∼11% MUFAs, and∼41% PUFAs. Among the most
abundant fatty acids were palmitic acid (∼30.5%) > linoleic
acid (∼23%) > stearic acid (∼17.5%) > arachidonic acid (AA)
(∼11%), while least quantitatively represented fatty acids were
eicosapentaenoic acid (EPA) and adrenic acid (∼0.3–0.4%).
Within PUFAs, the proportion of omega-6 was ∼10-fold higher
than that of omega-3 (∼37.4 vs. ∼3.6%). Comparisons of fatty
acid levels after vs. before the AMJ treatment in female subjects
revealed a significant decrease in AA/EPA ratio (29.17 ± 15.21
vs. 38.42 (25.96–89.58), respectively; Wilcoxon matched pairs
test, P = 0.02), as AA levels significantly decreased (10.18
± 2.16 vs. 11.16 ± 2.61 %, respectively; t-test for dependent
samples, P = 0.01) and EPA levels significantly increased (0.43
± 0.20 vs. 0.28 ± 0.12 %, respectively; t-test for dependent
samples, P = 0.04) (Supplementary Table 3). Along with AA,
dihomo-γ linolenic acid also decreased following the treatment
in women [2.34 (1.59–4.33)% vs. 2.89 ± 1.04%, respectively;
Wilcoxon matched pairs test, P= 0.02]. The same type of change
was observed for adrenic acid [0.34 ± 0.12% vs. 0.40 (0.23–
0.98)%, respectively; Wilcoxon matched pairs test, P = 0.003]
(Supplementary Table 3).
The changes (1, after vs. before treatment) in levels of
individual fatty acids did not significantly correlate with a change
(1) in LINE-1 methylation levels, with the exception of adrenic
acid (R= 0.60, R2 = 0.36, adjusted R2 = 0.31, P= 0.02). Multiple
regression models revealed no significant relations between a
change (1) in LINE-1 methylation levels and changes (1) in
levels of each class of fatty acids: SFAs (R = 0.53, R2 = 0.28,
adjusted R2 = 0.17, P = 0.13), MUFAs (R = 0.43, R2 = 0.18,
adjusted R2 = −0.04, P = 0.51), and PUFAs (R = 0.86, R2 =
0.74, adjusted R2 = 0.49, P = 0.09).
DISCUSSION
The main finding of this study is that the 4-week daily
consumption of A. melanocarpa juice decreased the LINE-1
methylation levels in peripheral blood leukocytes in women
with CVD risk factors, including overweight and dyslipidemia.
Daily treatment with Aronia melanocarpa juice, assigned as AMJ
treatment, contained 1.18 g of total polyphenols. This amount
corresponds to an estimated average daily intake of about 1 g of
total polyphenols from the dietary sources (31), provided that,
in the composition of aronia polyphenols, the most abundant
are anthocyanins, proanthocyanidins, hydroxycinnamic acids,
and flavonols (32), which is in compliance with the findings
of a previous study that characterized the composition of
aronia juice used in the current research (24). Confirmation
that the currently demonstrated significant reduction in LINE-
1 methylation is due to the impact of polyphenols, rather than
of other bioactive components of aronia juice, lies in the fact
that placebo treatment exerted no significant effects on LINE-
1 methylation. In line with this study, global DNA methylation
levels in peripheral leukocytes were significantly reduced after
2-week-long consumption of polyphenol-rich cocoa product, in
individuals at cardiovascular risk (13).
Herein observed decreased DNA methylation levels after the
consumption of polyphenol-rich aronia juice may be attributed
to the role of polyphenols as natural DNMT inhibitors (22).
Namely, catechins and their metabolites, which belong to
one of the main aronia polyphenol classes—proanthocyanidins
(32), can increase the production of S-adenosyl-L-homocysteine
(SAH), a potent inhibitor of DNMTs and a participant of the
folate-methionine cycle, through the inhibition of catechol-O-
methyltransferase (COMT)-mediated O-methylation of catechol
substrates (33, 34). Among the main endogenous substrates
for both liver and leukocyte, COMT is a catechol estrogen
(33, 35), potentially explaining the finding of the present
methylation analysis exclusively in women. In addition, catechins
suppress MTHFR activity, hence blocking the folate-methionine
cycle and reducing the methyl group bioavailability (36). The
antioxidant and anti-inflammatory activities of polyphenol-rich
aronia products, by which they contribute to cardiovascular
protection (17, 37), might be attributed to the role of polyphenols
as DNMT inhibitors. By reducing the activity of DNMTs, the
prevalent aronia flavonol, quercetin, decreases the promoter
methylation levels and activates the expression of target genes,
such as a transcription regulator nuclear factor erythroid 2-
related factor 2 (38), which is involved in the anti-inflammatory
and antioxidant mechanisms in vascular cells and macrophages
(38–40). Moreover, aronia polyphenols may be involved in the
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inflammatory response by affecting the activity/production of
DNMTs via cytokines, since it has been demonstrated that aronia
anthocyanins affected the production of inflammatory mediators
(37), and under the influence of IL-1, there have been changes in
DNMT expression and genomic methylation in human cells in
vitro (41).
With regard to our results, the proposed mechanisms of
polyphenol-induced inhibition of DNA methylation (33, 34, 36)
would depend on daily folate intake and MTHFR C677T gene
variant. We found that the change (after vs. before the AMJ
treatment) in LINE-1 methylation levels in women correlated
directly with average daily folate intake, and this is consistent
with previously defined effects of folate on the modulation
of DNA methylation (4). Concerning the effects of MTHFR
C677T gene variant, our finding is in line with the study of
Nojima et al. (42), which showed that the global methylation
levels in peripheral blood leukocytes were significantly increased
in carriers of the 677T allele. This was obtained when the
MTHFR variant was analyzed in interaction with another factor
that affected the methylation of DNA—an inflammatory marker
blood concentration (42). Similarly, except with folate intake,
our regression model denoted an interaction of the MTHFR
variant with circulating LDL-C and triacylglycerol levels, as
metabolic factors have been associated with LINE-1 methylation
(9, 10, 43). Namely, the current change in LINE-1 methylation
in women correlated positively with the change in LDL-C and
negatively with the change in triacylglycerols, which should be
pointed out along with the fact that our female subjects are
dyslipidemic. So far, few studies have investigated the relationship
between LINE-1 methylation and lipid profile and yielded
conflicting results (9, 10, 43), emphasizing the need for further
research. The present positive correlation of peripheral blood
leukocyte LINE-1 methylation with circulating LDL-C levels is
in line with two studies, which have investigated middle-aged
subjects with cardiovascular risk factors and no evidence of
CVD (10, 43). Since we have established this positive correlation
between changes in LINE-1 methylation and circulating LDL-
C levels in subjects whose LINE-1 methylation was significantly
decreased, following the consumption of aronia juice, our finding
may support the currently proposed cardioprotective action
of polyphenol-rich aronia products attributed to the role of
polyphenols as DNMT inhibitors. Accordingly, the same type
of correlation would be expected between changes in LINE-
1 methylation and serum triacylglycerols levels, but we found
them to correlate inversely. Still, findings regarding the link
of LINE-1 methylation with serum triacylglycerols are rather
inconsistent, as one of the mentioned studies reported a positive
correlation (10), while in the other there was no significant
relation (43). With respect to pathogenesis of CVD and the
proposed explanation, LDL-C was shown to cause vascular
endothelial dysfunction in part by changing the DNMT activity
and thus altering the DNAmethylation, given that, in endothelial
cells, LDL-C inhibited the transcription of a gene important
in maintaining the endothelial function, KLF2, through the
activation of DNMT1 (44).
Along with the investigated classical lipid parameters
(circulating cholesterol and triacylglycerols), we examined
plasma fatty acids profile in women who consumed polyphenol-
rich aronia juice, since the treatment significantly changed the
LINE-1 methylation levels only in these individuals, and this
change in LINE-1 methylation was found to correlate with the
changes in lipid parameters. We observed a significant reduction
of the AA/EPA ratio due to a significant decrease in plasma AA
and a significant increase in EPA levels, in target dyslipidemic
female subjects who underwent AMJ treatment. Similarly, in a
larger group of study participants at cardiovascular risk, from
which our substudy group was sorted out, there had also been a
significant AA/EPA reduction in aronia polyphenols consumers,
noting that this reduction had been due to a significant
decrease in AA, while EPA had not increased significantly (23).
Furthermore, in a recent study that has investigated the link
between FADS2 gene variants, fatty acid metabolism, and aronia
polyphenol intake in the overweight, there was a trend of
AA/EPA reduction in individuals who consumed aronia juice,
compared to placebo consumers (45). There has been evidence
for an association between total plasma AA and ischemic
stroke (46), and the increase in circulating EPA levels has been
shown to have beneficial effects on cardiovascular health (47).
Both findings (46, 47) are expected because the ratio of AA
to EPA reflects regulatory mechanisms of the inflammatory
process, as these two PUFAs compete for the conversion to
two classes of bioactive eicosanoids: pro- and anti-inflammatory
(48, 49). Hence, in addition to the well-known markers, such
as circulating total cholesterol, LDL-C, and triacylglycerols, the
AA/EPA ratio has recently been identified as a sensitive marker
of cardiovascular risk, given that a lower AA/EPA ratio was
associated with a decreased risk of coronary artery disease,
acute coronary syndrome, myocardial infarction, stroke, chronic
heart failure, and peripheral artery disease [reviewed in Davinelli
et al. (50)]. Our female study subjects who consumed aronia
juice had high baseline AA/EPA levels, indicating a chronic
low-grade inflammation and an increased risk of cardiovascular
events. Thus, a significant decrease in AA/EPA ratio following
the AMJ treatment is in line with proposed anti-inflammatory
and cardioprotective effects of aronia juice polyphenols, also
supporting a suggested relation of these effects with the currently
observed decrease in LINE-1methylation levels in women.
The findings of the present study should be interpreted in
light of limiting factors, primarily a sample size. Nevertheless, the
study design has strength regarding the measurement of LINE-1
methylation levels both before and after each applied treatment,
together with the corresponding anthropometric and metabolic
parameters, allowing the accurate determination of treatment-
dependent changes in parameter values. Another strength of
the study is the use of a reliable food frequency questionnaire
for the baseline dietary intake assessment with the subsequent
analysis of data collected from 24-h dietary recalls, performed
by using a validated nutritional platform for comprehensive diet
evaluation. This allowed balancing of baseline dietary intake
of the study subjects across each of the two interventional
treatments, assuming that dietary intake did not change within
the 4-week treatment period. Still, the possible confounding
effects of temporal changes in dietary habits may not be excluded
and represent a limiting factor of the study design. Another
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limiting factor is a possible interindividual variability in response
to polyphenol treatment, related to polyphenol bioavailability
and other factors that fell beyond the scope of this study.
In conclusion, the main novelty brought by the present study
is a change in LINE-1methylation levels after the 4-week habitual
consumption of polyphenol-rich aronia juice, which indicates an
impact of aronia polyphenols on DNA methylation. The current
results suggest cardioprotective effects of aronia polyphenols
in subjects at CVD risk, achieved through the modifications
of LINE-1 DNA methylation pattern and AA/EPA ratio. Our
findings merit further investigation, particularly in view of the
fact that the precision nutrition-drivenmodulations of bothDNA
methylation and PUFA profile may become pertinent targets for
new approaches in the prevention and treatment of CVD.
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